BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10071306)

  • 1. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors.
    Reich S; Overberg-Schmidt US; Bührer C; Henze G
    J Clin Oncol; 1999 Mar; 17(3):1086. PubMed ID: 10071306
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of desmoid tumors and fibromatosis using vinorelbine.
    Weiss AJ; Horowitz S; Lackman RD
    Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
    Caglar K; Ozyönüm H; Akalin M; Balci S
    Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful low-dose chemotherapy using vinblastine and methotrexate for the treatment of an ileoanal pouch mesenteric desmoid tumor: report of a case.
    Kono T; Tomita I; Chisato N; Matsuda M; Kakisaka A; Kasai S
    Dis Colon Rectum; 2004 Feb; 47(2):246-9. PubMed ID: 15043298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
    Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
    Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
    Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
    J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful combined treatment for giant mesenteric desmoid tumor: case report and review of the literature.
    Federici S; Mordenti M; Domenichelli V; Pelusi G; Straziuso S; Pericoli R
    J Pediatr Surg; 2012 Jun; 47(6):e25-30. PubMed ID: 22703821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
    Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
    J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Facial infantile aggressive fibromatosis: a frequent localization of an exceptional tumor!].
    Bouguila J; Khonsari RH; Zitouni K; Zairi I; Adouani A
    Ann Chir Plast Esthet; 2012 Jun; 57(3):304-7. PubMed ID: 20561731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP)].
    Pilz T; Pilgrim TB; Bisogno G; Knietig R; Koscielniak E; Carli M; Treuner J
    Klin Padiatr; 1999; 211(4):291-5. PubMed ID: 10472564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
    Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy in adult desmoid tumors.
    Patel SR; Evans HL; Benjamin RS
    Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
    Nishida Y; Hamada S; Urakawa H; Ikuta K; Sakai T; Koike H; Ito K; Emoto R; Ando Y; Matsui S
    Cancer Sci; 2020 Nov; 111(11):4187-4194. PubMed ID: 32816351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
    Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG
    Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image Gallery: Complete remission of aggressive desmoid-type fibromatosis after low-dose methotrexate for 2 weeks in a child with psoriasis.
    Simonsen S; Vera Casaño A; Gómez Moyano E; Sanz Trelles A; Bravo Bravo C; Martínez Pilar L
    Br J Dermatol; 2016 Oct; 175(4):e122. PubMed ID: 27650749
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of aggressive fibromatosis by treatment with imatinib mesylate: a step forward?
    Ravaioli A; Nicoletti S; Tamburini E; Papi M
    J Cancer Res Clin Oncol; 2009 Feb; 135(2):325-6. PubMed ID: 18825412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
    Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
    Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive fibromatosis in children and adolescents: the Italian experience.
    Meazza C; Bisogno G; Gronchi A; Fiore M; Cecchetto G; Alaggio R; Milano GM; Casanova M; Carli M; Ferrari A
    Cancer; 2010 Jan; 116(1):233-40. PubMed ID: 19950127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
    Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
    Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.